ORCL · News · 20261103N
Capital Funding and Liquidity
ORACLE CORP · 2026-11-03 · Importance 64 · Surprise 42 · No source text
Oracle priced concurrent offerings totaling $20 billion: approximately $10 billion of common stock and $10 billion of senior notes, to support its AI and cloud infrastructure investment cycle. It priced 86,206,897 shares at $116 each, an 11.2% discount to the Oct. 30 closing price, and notes in five tranches due from 2029 to 2046 with coupons ranging from 7.000% to 8.650%. The offerings were expected to close Nov. 4, 2026, subject to customary conditions. Reported uses of proceeds include capital expenditures, debt repayment, investments, acquisitions, dividends and share repurchases; coverage also noted Oracle’s stated limit on additional capital-markets funding through fiscal 2030.
Key facts
- Oracle plans to raise $20 billion through debt and equity—$10 billion in common stock and $10 billion in bonds—to fund AI infrastructure development, despite an earlier statement that it would not seek more than $20 billion in additional capital-markets funding through fiscal 2030. source
- Oracle announced it would raise approximately $20 billion through concurrent equity and debt offerings to fund AI growth initiatives; capital may be used for capital expenditures, debt repayment, investments, acquisitions, dividends, and share repurchases. source
- Oracle priced a $20 billion financing package, with approximately $10 billion in common shares and $10 billion in bonds; it expects about $9.9 billion in net proceeds from the equity sale. source
- Oracle's $10 billion senior-note offering comprised five series with maturities from 2029 to 2046 and interest rates ranging from 7% to 8.65%; the offerings were expected to close November 4, with proceeds available for capital spending, debt repayment, acquisitions, dividends, and share buybacks. source
- According to people familiar with the matter, Oracle was poised to price a $10 billion share sale at $116 per share, an 11% discount to Friday's close of $130.67; pricing details could still change. source
- Oracle's $20 billion capital raise was described as a $10 billion bond sale concurrent with a $10 billion stock offering to meet its fiscal year 2030 capital-raise cap. source
- Oracle priced 86,206,897 common shares at $116.00 per share in a public offering. source
- Oracle priced $10 billion of senior notes in five tranches: $2 billion of 7.000% notes due 2029, $1.75 billion of 7.450% notes due 2031, $2.25 billion of 7.850% notes due 2033, $2.5 billion of 8.000% notes due 2037, and $1.5 billion of 8.650% notes due 2046. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| liability | negative | committed | -3.3% | Oracle priced $10 billion of senior notes in five tranches: $2 billion of 7.000% notes due 2029, $1.75 billion of 7.450% notes due 2031,… |
| cash | positive | committed | +3.2% | Oracle priced a $20 billion financing package, with approximately $10 billion in common shares and $10 billion in bonds; it expects about… |
| net_income | negative | committed | -1.0% | Oracle priced $10 billion of senior notes in five tranches: $2 billion of 7.000% notes due 2029, $1.75 billion of 7.450% notes due 2031,… |
| cash | negative | committed | -0.3% | Oracle priced $10 billion of senior notes in five tranches: $2 billion of 7.000% notes due 2029, $1.75 billion of 7.450% notes due 2031,… |